Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Transplantation
|
June 27, 1995
Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice
M Zeis, L Uharek, B Glass, et al.
Leukemia
|
November 1, 1996
High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2
L Uharek, M Zeis, B Glass, et al.
British Journal of Haematology
|
July 1, 1991
High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential
W Gassmann, L Uharek, A Erbersdobler, et al.
Seminars in Oncology
|
October 1, 1993
Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group
W Hiddemann, M Unterhalt, C Pott, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 16, 1984
[IgD plasmacytoma]
W Gassmann, T Haferlach, K H Engelhardt, et al.
Phytopathology
|
October 24, 2008
Is Change in Electrical Potential or pH a Hatching Signal for Heterodera glycines?
S M Pike, R Heinz, T Walk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy
M Engelhard, P Meusers, G Brittinger, et al.
Haematology and Blood Transfusion
|
January 1, 1987
Postinduction and preremission chemotherapy alternatives for adult AML: three multicenter studies of the AML Cooperative Group
T Büchner, W Hiddemann, D Urbanitz, et al.
Annals of Hematology
|
May 1, 1993
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease
N Schmitz, B Glass, P Dreger, et al.
Blood
|
March 15, 1996
The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization
T Haferlach, M Winkemann, H Löffler, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Transplantation
|
June 27, 1995
Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice
M Zeis, L Uharek, B Glass, et al.
Leukemia
|
November 1, 1996
High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2
L Uharek, M Zeis, B Glass, et al.
British Journal of Haematology
|
July 1, 1991
High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential
W Gassmann, L Uharek, A Erbersdobler, et al.
Seminars in Oncology
|
October 1, 1993
Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group
W Hiddemann, M Unterhalt, C Pott, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 16, 1984
[IgD plasmacytoma]
W Gassmann, T Haferlach, K H Engelhardt, et al.
Phytopathology
|
October 24, 2008
Is Change in Electrical Potential or pH a Hatching Signal for Heterodera glycines?
S M Pike, R Heinz, T Walk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy
M Engelhard, P Meusers, G Brittinger, et al.
Haematology and Blood Transfusion
|
January 1, 1987
Postinduction and preremission chemotherapy alternatives for adult AML: three multicenter studies of the AML Cooperative Group
T Büchner, W Hiddemann, D Urbanitz, et al.
Annals of Hematology
|
May 1, 1993
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease
N Schmitz, B Glass, P Dreger, et al.
Blood
|
March 15, 1996
The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization
T Haferlach, M Winkemann, H Löffler, et al.
Page
of 11